Expression profiling of the influence of RAS mutants on the TGFB1‐induced phenotype of the pancreatic cancer cell line PANC‐1
暂无分享,去创建一个
Malte Buchholz | Peter Gierschik | Hans A Kestler | H. Kestler | T. Gress | M. Buchholz | G. Adler | V. Ellenrieder | P. Gierschik | Guido Adler | Volker Ellenrieder | K. Giehl | Heiko Fensterer | Klaudia Giehl | Thomas M Gress | Anita Buck | Anita Buck | H. Fensterer
[1] S. Markowitz,et al. Tumor suppressor activity of the TGF-beta pathway in human cancers. , 1996, Cytokine & growth factor reviews.
[2] T. Seufferlein,et al. Transforming growth factor alpha activates Ha-Ras in human pancreatic cancer cells with Ki-ras mutations. , 1999, Gastroenterology.
[3] A. Schulze,et al. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. , 2000, Genes & development.
[4] J. Bos,et al. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras , 1997, Oncogene.
[5] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[6] Anita B. Roberts,et al. Tumor suppressor activity of the TGF-β pathway in human cancers , 1996 .
[7] R. L. Baldwin,et al. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. , 1993, Cancer research.
[8] Hideji Nakamura,et al. Hepatoma-derived Growth Factor Stimulates Cell Growth after Translocation to the Nucleus by Nuclear Localization Signals* , 2002, The Journal of Biological Chemistry.
[9] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Massagué,et al. Controlling TGF-β signaling , 2000, Genes & Development.
[11] E. Friedman,et al. Oncogenic Ki-ras Confers a More Aggressive Colon Cancer Phenotype through Modification of Transforming Growth Factor-β Receptor III* , 2001, The Journal of Biological Chemistry.
[12] H. Beug,et al. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. , 1996, Genes & development.
[13] E. Hay. An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.
[14] J. Zavadil,et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Massagué,et al. Controlling TGF-beta signaling. , 2000, Genes & development.
[16] T. Seufferlein,et al. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. , 2001, Cancer research.
[17] R. Derynck,et al. TGF-beta signaling in cancer--a double-edged sword. , 2001, Trends in cell biology.
[18] L. Feig. Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases , 1999, Nature Cell Biology.
[19] H. Friess,et al. A pancreatic cancer-specific expression profile. , 1996, Oncogene.
[20] H. Friess,et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival , 1993 .
[21] G. Adler,et al. TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation , 2000, Oncogene.
[22] Peter Gierschik,et al. Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration , 2000, Oncogene.
[23] M. Nakajima,et al. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Massagué,et al. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.
[25] T. Gress,et al. TGF‐β–induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase‐2 and the urokinase plasminogen activator system , 2001, International journal of cancer.
[26] H. Friess,et al. Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis , 1997, Genes, chromosomes & cancer.
[27] A. Schulze,et al. Analysis of the transcriptional program induced by Raf in epithelial cells , 2001, Nature Genetics.
[28] K. Guan,et al. The Dominant Negative Ras Mutant, N17Ras, Can Inhibit Signaling Independently of Blocking Ras Activation* , 2000, The Journal of Biological Chemistry.
[29] J. Downward,et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis , 2002, The Journal of Cell Biology.
[30] W. Kabsch,et al. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. , 1997, Science.
[31] J. Downward,et al. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. , 2002, The Journal of cell biology.
[32] W. Birchmeier,et al. Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells , 1993, Journal of Cell Science.
[33] J. Massagué,et al. Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. , 1996, Cancer surveys.
[34] R. Hruban,et al. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. , 1998, Cancer research.
[35] D. Botstein,et al. The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.
[36] D. Welch. Transforming growth factor β stimulates mamary adenocarcinoma cell invasion and metastasis potential , 1990 .
[37] E. Friedman,et al. Transforming Growth Factor β1 Induces Proliferation in Colon Carcinoma Cells by Ras-dependent, smad-independent Down-regulation of p21cip1* , 2002, The Journal of Biological Chemistry.
[38] M. Korc,et al. Role of growth factors in pancreatic cancer. , 1998, Surgical oncology clinics of North America.
[39] K. M. Mulder,et al. Transforming Growth Factor β Activation of p44mapk in Proliferating Cultures of Epithelial Cells (*) , 1995, The Journal of Biological Chemistry.